DISCOVER
CORPORATE NEWS
2025 - PR Telemedicine Technologies and Micron Join Forces Under the CRO Alliance 2024 - PR TTelemedicine Technologies & Artialis partner for clinical research innovation - PR Telemedicine Technologies wins BSMA Clinical Trials Supply Chain Award for groundbreaking CleanWeb™-RTSM module - PR Revenues 2023 2023 - PR VisionHM listed at UGAP - PR acquisition of the French start-up CTMA - PR FY2023 Q1 results - PR FY2023 Q2 results - PR TTSA joins 40-Partner Consortium in xShare Initiative 2022 - PR acquisition of the Swiss company DAPSYS - PR BSA AIR - PR new facilities in Laval, France - PR new facilities in Liège, Belgium - PR FY2022 results 2021 - PR acquisition of the Belgian eCRO Lambda-Plus - PR VisionHM listed at UniHA
Contact
Investors relation
OUR STORY,
OUR STRENGTH
Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
May 28, 2026
Applied Clinical Trials Online Safety monitoring generates substantial signal volume across risk-based quality management tools, but only 30% to 36% of signals correspond to confirmed issues, suggesting the need for better prioritization, signal consolidation, and alignment between detection and proportional action. Safety reporting is a critical aspect of clinical trial quality, directly impacting patient safety […]
May 28, 2026
Med City News When coordinators are buried in documentation, scheduling, and data reconciliation, patient engagement is the first thing to go. And when engagement drops, retention drops with it. Clinical trials are powered by people: patients who volunteer, and site teams who sustain them. Yet the modern trial increasingly asks both groups to absorb rising […]
May 28, 2026
FDA The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the successful initiation of two proof-of-concept clinical trials that will report endpoints and data signals to the agency in real time. Second, the agency released […]